Anthony Galvez, Paige Kuhlmann, Margot Barker, Andrew Chen, Victoria Scott, Karyn Eilber, Jennifer Anger
{"title":"Association of HRQOL with Symptom Patterns in an Online Cohort of Patients with Interstitial Cystitis/Bladder Pain Syndrome.","authors":"Anthony Galvez, Paige Kuhlmann, Margot Barker, Andrew Chen, Victoria Scott, Karyn Eilber, Jennifer Anger","doi":"10.1016/j.urology.2025.06.054","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To explore the differences in symptom patterns and management between individuals with IC/BPS who have high vs low self-reported health related quality of life (HRQOL).</p><p><strong>Methods: </strong>An anonymous 40-question online survey assessed IC/BPS patients' symptoms, triggers, management strategies, and comorbidities. Recruitment was through the Interstitial Cystitis Association's Facebook page. HRQOL was rated on a 0-10 Likert scale, grouping respondents into low-impact (0-3), intermediate (4-6), and high-impact (7-10). Univariate analysis included chi-square, Fisher's exact test, and t-tests.</p><p><strong>Results: </strong>Among 451 respondents, 53 (12%) reported low disease impact, while 279 (62%) had high impact. The high-impact group was more frequently triggered by mental health issues (50% vs 32%, p=0.016) and exercise (14% vs 4%, p=0.040), while the low-impact group was more often triggered by allergies (6% vs 1%, p=0.054) and coffee (11% vs 3%, 0.005). High-impact individuals had higher rates of comorbidities including pelvic floor dysfunction (39% vs 19%, 0.005), irritable bowel syndrome (36% vs 21%, p=0.029), overactive bladder (30% vs 17%, p=0.051), and/or vulvodynia (23% vs 9%, p=0.026).</p><p><strong>Conclusions: </strong>IC/BPS encompasses a spectrum of disease manifestations. While demographics remain relatively uniform in this IC/BPS population, symptom patterns, comorbidities, and therapeutic choices are correlated with impact on quality of life.</p>","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.urology.2025.06.054","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: To explore the differences in symptom patterns and management between individuals with IC/BPS who have high vs low self-reported health related quality of life (HRQOL).
Methods: An anonymous 40-question online survey assessed IC/BPS patients' symptoms, triggers, management strategies, and comorbidities. Recruitment was through the Interstitial Cystitis Association's Facebook page. HRQOL was rated on a 0-10 Likert scale, grouping respondents into low-impact (0-3), intermediate (4-6), and high-impact (7-10). Univariate analysis included chi-square, Fisher's exact test, and t-tests.
Results: Among 451 respondents, 53 (12%) reported low disease impact, while 279 (62%) had high impact. The high-impact group was more frequently triggered by mental health issues (50% vs 32%, p=0.016) and exercise (14% vs 4%, p=0.040), while the low-impact group was more often triggered by allergies (6% vs 1%, p=0.054) and coffee (11% vs 3%, 0.005). High-impact individuals had higher rates of comorbidities including pelvic floor dysfunction (39% vs 19%, 0.005), irritable bowel syndrome (36% vs 21%, p=0.029), overactive bladder (30% vs 17%, p=0.051), and/or vulvodynia (23% vs 9%, p=0.026).
Conclusions: IC/BPS encompasses a spectrum of disease manifestations. While demographics remain relatively uniform in this IC/BPS population, symptom patterns, comorbidities, and therapeutic choices are correlated with impact on quality of life.
期刊介绍:
Urology is a monthly, peer–reviewed journal primarily for urologists, residents, interns, nephrologists, and other specialists interested in urology
The mission of Urology®, the "Gold Journal," is to provide practical, timely, and relevant clinical and basic science information to physicians and researchers practicing the art of urology worldwide. Urology® publishes original articles relating to adult and pediatric clinical urology as well as to clinical and basic science research. Topics in Urology® include pediatrics, surgical oncology, radiology, pathology, erectile dysfunction, infertility, incontinence, transplantation, endourology, andrology, female urology, reconstructive surgery, and medical oncology, as well as relevant basic science issues. Special features include rapid communication of important timely issues, surgeon''s workshops, interesting case reports, surgical techniques, clinical and basic science review articles, guest editorials, letters to the editor, book reviews, and historical articles in urology.